Change in curve changed the ratio of Cmax [Bioanalytics]

posted by Dr_Dan  – Germany, 2015-03-24 12:05 (3715 d 12:44 ago) – Posting: # 14609
Views: 12,330

Dear Compliance
So the difference in Cmax ratio is due to the different number of test/reference comparisons since you now have additional profiles which were not available before due to the poor sensitivity of the first method, right?
In this case the first method is not appropriate to evaluate the study. According to the European BE guidelines the lower limit of quantitation should be 1/20 of Cmax or lower, as pre-dose concentrations should be detectable at 5% of Cmax or lower. I do not know if EMA considers the mean Cmax or the individual profiles. How many subjects/periods do you have with a Cmax between 0.25 ng/ml and 1.0 ng/ml?
However, to answer nobody´s question: The slopes of the individual profiles do not differ, right?
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
23 visitors (0 registered, 23 guests [including 5 identified bots]).
Forum time: 01:50 CEST (Europe/Vienna)

An expert is someone who knows some of the worst mistakes
that can be made in his subject,
and how to avoid them.    Werner Heisenberg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5